News

June 03, 2021

Waigaoqiao pharma giant wins city quality gold award

Recently, Shanghai Pharmaceutical Holdings Ltd., based in the Waigaoqiao Bonded Area, won the “2020 Shanghai Quality Gold Award.”

The “Shanghai Quality Gold Award” is mainly bestowed on units with excellent quality management, strong capacity for independent innovation, and leading economic and social contributions to the city.

Shanghai Pharmaceutical Holdings, which is directly under Shanghai Pharmaceutical Group Corp., is a nationwide modern pharmaceutical supply chain service enterprise with its network of operation centers spreading across 17 provinces and cities.

Based on its nationwide terminal network, it focuses on promoting hospital supply chain services, developing “new distribution and new retail” and building new industrial advantages. The company’s distribution network covers more than 30,000 medical institutions nationwide, and it has favorable industry advantages based on its strong terminal network and service innovation, and strong industrial competitiveness in new business areas such as high-end consumables, DTP (direct delivery of high-value drugs) and SPD (in-hospital logistics services for pharmaceutical products).

Shanghai Pharmaceutical Holdings has expanded its product collection, operating more than 20,000 kinds of drugs, established important partnerships with the world’s Top 20 pharmaceutical multinationals, and basically achieved full coverage of the top 100 pharmaceutical companies’ varieties listed by the Ministry of Industry and Information Technology.